Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Nov;103(11):2694-9.
doi: 10.1111/j.1572-0241.2008.02191.x. Epub 2008 Oct 3.

Continuing rapid increase in esophageal adenocarcinoma in England and Wales

Affiliations

Continuing rapid increase in esophageal adenocarcinoma in England and Wales

Côme Lepage et al. Am J Gastroenterol. 2008 Nov.

Abstract

Background and aims: Substantial changes have occurred in the epidemiology of esophageal adenocarcinoma. We examined trends in incidence in a large national population.

Methods: All esophageal adenocarcinomas registered in England and Wales over a 31-year period (1971-2001) were included. Incidence rates were calculated by age, sex, and socio-economic category, by 5-year period, and by birth cohort.

Results: A total of 43,753 esophageal adenocarcinomas were analyzed. Age-standardized (world) incidence rates rose rapidly, by an average of 39.6% (95% CI 38.6-40.6) every 5 years in men, and 37.5% (35.8-39.2) every 5 years in women. Incidence has increased about three-fold in men and women since 1971. Incidence has risen in all deprivation categories since 1986, especially in the most affluent groups. The cumulative risk of esophageal adenocarcinoma over the age range 15-74 years in men rose ten-fold, from 0.1% for those born in 1900 to 1.1% for those born in 1940. The cumulative risk rose five-fold in women.

Conclusions: The incidence of esophageal adenocarcinoma has increased sharply over the past few decades, both by period and birth cohort. Etiological studies are required to explain the rapid increase of this lethal cancer.

PubMed Disclaimer

Publication types